Orthofix Medical Inc.
OFIX Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$9.78
KIRA · Stoqly’s AI analyst, in plain words
- Orthofix Medical Inc. had $822M of revenue in fiscal 2025, up 2.9% on the year before. Over five years, revenue changed +15.1% a year on average.
- Its operating margin was −9.9%, up 0.7 pts: of every 100 in sales, about −10 is left after running the business.
- Orthofix Medical Inc. lost $92.2M in fiscal 2025.
- Free cash flow was −$1.3M in fiscal 2025, −0.2% of revenue.
- Orthofix Medical Inc. owes $93.3M more than it holds in cash.
Market cap
$400M
P/E
—
Revenue
$822M
Net income
−$92.2M
Free cash flow
−$1.3M
Operating margin
−9.9%
Orthofix Medical Inc. in 30 seconds · fiscal 2025
Are sales growing?
+2.9%
Only a little. Sales grew 2.9% last year.
Does it make a profit?
−11.2%
No. It lost money last year.
Does profit turn into cash?
−0.2%
No. It spent more cash than it brought in.
How healthy are the accounts?
5 / 9
Mixed. It passes 5 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Orthofix Medical Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 24, 2026
- Legal name
- Orthofix Medical Inc.
- CIK
- 0000884624
Orthofix Medical Inc. · OFIX
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $464M | $461M | $747M | $799M | $822M |
| Revenue growth | 14.2% | −0.8% | 62.1% | 7.1% | 2.9% |
| Net interest income | −$1.8M | −$1.3M | −$8.6M | −$29.6M | −$17.5M |
| Gross margin | 75.3% | 73.2% | 65.1% | 68.3% | 68.8% |
| Operating margin | −1.8% | −2.9% | −18.6% | −10.6% | −9.9% |
| Net income | −$38.4M | −$19.7M | −$151M | −$126M | −$92.2M |
| Net margin | −8.3% | −4.3% | −20.3% | −15.8% | −11.2% |
| Diluted EPS | −$1.95 | −$0.98 | −$4.12 | −$3.30 | −$2.33 |
| Cash | |||||
| Cash from operations | $18.5M | −$11.5M | −$45.8M | $25.8M | $33.3M |
| Capital expenditure | $17.8M | $21.4M | $60.3M | $34.9M | $34.6M |
| Free cash flow | $0.7M | −$32.9M | −$106M | −$9.1M | −$1.3M |
| FCF margin | 0.1% | −7.1% | −14.2% | −1.1% | −0.2% |
| Share count change | 1.5% | 1.8% | 83.2% | 3.8% | 3.9% |
| Debt and strength | |||||
| Cash and short-term investments | $87.8M | $50.7M | $33.1M | $83.2M | $82.0M |
| Debt incl. finance leases | — | — | $114M | $175M | $175M |
| Shareholders' equity | $337M | $337M | $599M | $503M | $450M |
| Current ratio | 2.5x | 3.1x | 2.5x | 2.6x | 2.4x |
| Returns and quality | |||||
| Return on capital | — | — | −16.7% | −11.6% | −12.2% |
| Return on equity | −11.1% | −5.9% | −32.4% | −22.9% | −19.3% |
| Return on tangible equity | −18.0% | −9.1% | −52.9% | −60.2% | −50.6% |
| Piotroski F-score | 4 | 4 | 1 | 6 | 5 |
| Altman Z'' | 4.8 | 5.2 | 2.2 | 1.7 | 1.0 |
Insiders bought, 12 months
$4.1M
4 insiders
Insiders sold, 12 months
$6.6M
9 insiders
Of sales under plans
0%
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Orthofix Medical Inc. · OFIX
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $9.78 a share, the company is worth $400M.
Source: SEC EDGAR XBRL filings (CIK 0000884624). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.